We did not evaluate the synergistic effect of KPT-185 as it already had a very strong inhibitory effect on PC9GR cells; however, its combination with other drugs might even be more effective in the treatment of EGFR-TKI-resistant lung cancer, which is one of our future plans. This evidence concerns the gene EGFR and lung cancer.